{"cik":"0001781174","ticker":"ACRV","name":"Acrivon Therapeutics, Inc.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"","fiscal_year_end":"1231","first_filing_date":"2026-05-13","last_filing_date":"2026-06-22","url":"/sec/cik-0001781174","insider_summary":{"total_transactions":41,"unique_insiders":19,"latest_transaction":"2026-07-21"},"recent_filings":[{"accession_number":"0000905148-26-004399","form_type":"4","form_type_family":"insider","doc_date":"2026-10-07","title":"4 — Acrivon Therapeutics, Inc. — 2026-10-07","url_slug":"/sec/cik-0001781174/4/0000905148-26-004399","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-004399-index.html"},{"accession_number":"0000905148-26-004065","form_type":"4","form_type_family":"insider","doc_date":"2026-09-02","title":"4 — Acrivon Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001781174/4/0000905148-26-004065","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-004065-index.html"},{"accession_number":"0000905148-26-004064","form_type":"3","form_type_family":"insider","doc_date":"2026-09-02","title":"3 — Acrivon Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001781174/3/0000905148-26-004064","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-004064-index.html"},{"accession_number":"0000905148-26-003968","form_type":"4","form_type_family":"insider","doc_date":"2026-08-27","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-27","url_slug":"/sec/cik-0001781174/4/0000905148-26-003968","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003968-index.html"},{"accession_number":"0000905148-26-003924","form_type":"144","form_type_family":"other","doc_date":"2026-08-25","title":"144 — Acrivon Therapeutics, Inc. — 2026-08-25","url_slug":"/sec/cik-0001781174/144/0000905148-26-003924","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003924-index.html"},{"accession_number":"0000905148-26-003840","form_type":"4","form_type_family":"insider","doc_date":"2026-08-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-003840","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003840-index.html"},{"accession_number":"0000905148-26-003839","form_type":"4","form_type_family":"insider","doc_date":"2026-08-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-003839","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003839-index.html"},{"accession_number":"0000905148-26-003838","form_type":"4","form_type_family":"insider","doc_date":"2026-08-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-003838","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003838-index.html"},{"accession_number":"0000905148-26-003837","form_type":"4","form_type_family":"insider","doc_date":"2026-08-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-003837","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003837-index.html"},{"accession_number":"0000905148-26-003836","form_type":"4","form_type_family":"insider","doc_date":"2026-08-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-003836","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003836-index.html"},{"accession_number":"0001875620-26-000015","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-08-13","title":"SCHEDULE 13G/A — Acrivon Therapeutics, Inc. — 2026-08-13","url_slug":"/sec/cik-0001781174/schedule-13g-a/0001875620-26-000015","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0001875620-26-000015-index.html"},{"accession_number":"0001193125-26-347003","form_type":"S-8","form_type_family":"other","doc_date":"2026-08-12","title":"S-8 — Acrivon Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001781174/s-8/0001193125-26-347003","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0001193125-26-347003-index.html"},{"accession_number":"0001193125-26-346859","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-12","title":"8-K — Acrivon Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001781174/8-k/0001193125-26-346859","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0001193125-26-346859-index.html"},{"accession_number":"0001193125-26-346819","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-12","title":"10-Q — Acrivon Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001781174/10-q/0001193125-26-346819","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0001193125-26-346819-index.html"},{"accession_number":"0000905148-26-003499","form_type":"4","form_type_family":"insider","doc_date":"2026-08-06","title":"4 — Acrivon Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0001781174/4/0000905148-26-003499","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003499-index.html"},{"accession_number":"0000905148-26-003334","form_type":"4","form_type_family":"insider","doc_date":"2026-07-23","title":"4 — Acrivon Therapeutics, Inc. — 2026-07-23","url_slug":"/sec/cik-0001781174/4/0000905148-26-003334","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003334-index.html"},{"accession_number":"0000905148-26-003035","form_type":"4","form_type_family":"insider","doc_date":"2026-06-22","title":"4 — Acrivon Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001781174/4/0000905148-26-003035","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003035-index.html"},{"accession_number":"0000905148-26-003033","form_type":"4","form_type_family":"insider","doc_date":"2026-06-22","title":"4 — Acrivon Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001781174/4/0000905148-26-003033","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-003033-index.html"},{"accession_number":"0001193125-26-274410","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-17","title":"8-K — Acrivon Therapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001781174/8-k/0001193125-26-274410","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0001193125-26-274410-index.html"},{"accession_number":"0000905148-26-002560","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-002560","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-002560-index.html"},{"accession_number":"0000905148-26-002558","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-002558","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-002558-index.html"},{"accession_number":"0000905148-26-002556","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-002556","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-002556-index.html"},{"accession_number":"0000905148-26-002553","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-002553","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-002553-index.html"},{"accession_number":"0000905148-26-002552","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-002552","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-002552-index.html"},{"accession_number":"0000905148-26-002551","form_type":"4","form_type_family":"insider","doc_date":"2026-05-20","title":"4 — Acrivon Therapeutics, Inc. — 2026-05-20","url_slug":"/sec/cik-0001781174/4/0000905148-26-002551","edgar_url":"https://www.sec.gov/Archives/edgar/data/1781174/0000905148-26-002551-index.html"}],"related_endpoints":{"profile":"/sec/ACRV/profile","timeline":"/sec/ACRV/timeline","peers":"/sec/ACRV/peers","insider_pulse":"/sec/ACRV/insider-pulse","insider_summary":"/sec/ACRV/insider-summary","insider_transactions":"/sec/ACRV/insider-transactions","form144":"/sec/ACRV/form144","holdings_as_filer":"/sec/ACRV/holdings","financial_facts":"/sec/ACRV/financial-facts","derivatives":"/sec/ACRV/derivatives","officers":"/sec/ACRV/officers","insider_network":"/sec/ACRV/insider-network","risk_flags":"/sec/ACRV/risk-flags","filings":"/sec/ACRV/filings","cross_topic_dossier":"/api/v1/dossier?ticker=ACRV"}}